Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Csquare Q3 2026: Record $66.1M Bookings, IPO Repays $1.1B Debt

Csquare, Inc. (NYSE:CSQR) filed its third-quarter 2026 earnings disclosure on November 9, 2026, reporting revenue of $302.3 million, record bookings, and balance sheet changes following its July 2026 initial public offering.

Manish Choudhary | 09 November 2026

TGE Plans 15-for-1 Share Consolidation at December 7 EGM

The Generation Essentials Group filed an 8-K on November 9, 2026, announcing an extraordinary general meeting scheduled for December 7, 2026, at which shareholders will vote on a 15-for-1 share consolidation intended to help the company regain compliance with NYSE minimum average closing share …

Manish Choudhary | 09 November 2026

NHI Posts $11.47 EPS on $541.6M NHC Portfolio Gain in Q3 2026

National Health Investors, Inc. filed its third-quarter 2026 earnings disclosure on November 9, 2026, reporting results for the quarter ended September 30, 2026, highlighted by a $541.6 million gain on the sale of its National Healthcare Corporation leased portfolio.

Vinay Lochav | 09 November 2026

Shutterstock 2026 Annual Meeting: Adams and Salzberg Nominated

Shutterstock, Inc. filed a definitive proxy statement on November 9, 2026, notifying stockholders of its 2026 Annual Meeting of Stockholders scheduled for December 22, 2026, at 10:00 a.m. Eastern Time via live webcast.

Nitish Kishor | 09 November 2026

Jane Street Group Reports 6.5% AXT Inc Stake

Jane Street Group, LLC filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 4,246,421 shares of AXT Inc common stock, representing 6.5% of the class, as of the triggering event date of November 3, 2026.

Shwetambri Chauhan | 09 November 2026

Xiaofeng Ma Files Schedule 13D Amendment 11 for ATA Creativity Global

Xiaofeng Ma and affiliated entities filed Amendment No. 11 to a Schedule 13D with the SEC on November 9, 2026, disclosing updated beneficial ownership of Common Shares in ATA Creativity Global following the termination of Ma Family Trust on September 25, 2026.

Anjali Anand | 09 November 2026

Myriad Genetics Grants Retention Stock Options to Wheeler, Verratti, Muzzey

Myriad Genetics, Inc. filed a Form 8-K on November 9, 2026, disclosing that its Compensation and Human Capital Committee approved one-time retention stock option awards for three named executive officers on November 6, 2026.

Anjali Anand | 09 November 2026

Goosehead Insurance Flags Restatement for 2023-2026 Periods

Goosehead Insurance, Inc. filed a Form 8-K on November 9, 2026, disclosing that its Audit Committee determined previously issued financial statements for fiscal years 2023 through 2026 interim periods should no longer be relied upon and must be restated.

Anjali Anand | 09 November 2026

Aldeyra Seeks FDA Division Transfer for ADX-2191 in PVRL

Aldeyra Therapeutics, Inc. filed a Form 8-K on November 9, 2026, disclosing that it has formally requested a review jurisdiction transfer for its ADX-2191 Investigational New Drug application and has withdrawn the previously agreed Special Protocol Assessment protocol for the treatment of primary vitreoretinal …

Shwetambri Chauhan | 09 November 2026

Lantronix Q1 Fiscal 2027 Results Announced Nov. 9

Lantronix, Inc. filed a current report on November 9, 2026, disclosing its financial results for the first fiscal quarter ended September 30, 2026, alongside a transcript of management's prepared remarks for the accompanying investor conference call.

Vinay Lochav | 09 November 2026
Support

Hi! How can we help you today?

Loading…